MEDP
Medpace Holdings, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #823
- Final score
- 28.15
- Years on list
- 4
↗ Climbed 34 since 2023
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 34 since 2023
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 160 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 344 since 2021
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | MEDP | BMRN | SHC |
|---|---|---|---|
| Climate Change | 34.8 | 24.0 | 21.7 |
| Employee Relations | 35.2 | 34.5 | 35.9 |
| Environment | 13.4 | 20.4 | 19.2 |
| Stakeholders & Society | 18.3 | 29.8 | 17.0 |
| Human Rights | 21.6 | 27.2 | 44.6 |
| Governance | 40.3 | 36.5 | 25.6 |
| Performance Rating | 48.4 | 59.3 | 49.2 |